-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: 2011 BIO International Convention
Building the Case for Biotechnology Booksigning Today at BIO
Thanks to Yali (BIO Official Blogger) for reminding us that Mark Ahn, Michael Alvarez, and Anne York, the editors of Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business will be signing books today at the 2011 BIO International Convention in Washington DC from 3:00-4:30 pm in the BIO bookstore.
Biotech Patenting and Tech Transfer at 2011 BIO International Convention
The Biotech Patenting and Tech Transfer track has a lot to offer 2011 BIO International Convention Attendees. High level speakers include White House Intellectual Property Enforcement Coordinator Victoria Espinel, European Patent Office Director of Biotechnology Sjoerd Hoekstra, retired Chief Judge of the U.S. Court of Appeals for the Federal Circuit Paul Michel, and former Solicitors General Seth Waxman and Paul Clement to name a few. I am particularly excited about the breadth of the Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: 2011 BIO International Convention, BIO, biosimilars, Biotech Patenting, collaboration, Collaborative R&D, Compulsory Licensing, Counterfeiting, EPO, Myriad Case, Patent Linkage, Patents in the Supreme Court, Paul Clement, Paul Michel, Seth Waxman, Sjoerd Hoekstra, Tech Transfer, Technology Transfer, Victoria Espinel
Tags: 2011 BIO International Convention, BIO, biosimilars, Biotech Patenting, collaboration, Collaborative R&D, Compulsory Licensing, Counterfeiting, EPO, Myriad Case, Patent Linkage, Patents in the Supreme Court, Paul Clement, Paul Michel, Seth Waxman, Sjoerd Hoekstra, Tech Transfer, Technology Transfer, Victoria Espinel
BIO CEO Jim Greenwood in Washington Business Journal
Jeff Porro’s recent article, “Speaking to Rise”, in the Washington Business Journal features an interview with Biotechnology Industry Organization (BIO) President and CEO, Jim Greenwood. Jim will be giving the keynote address for this year’s BIO International Convention in DC June 27-30, and suggests that the best way to discuss difficult topics like biotechnology is to “put a human face on the subject matter” and to make the material relatable to the audience. When addressing Read More >
2011 Business Forum Onsite Partnering Tips
Now that all the prep-work is (almost!) done, the next step for us is to give you some partnering tips while you’re actually partnering! First and foremost, we will be on-site if you have any questions or need assistance with your meetings. We will gladly assist you in rescheduling, plain-old last-minute scheduling, and whatever else may arise. Please keep in mind, however, that while we are always on hand, we won’t necessarily be able to Read More >
Three dealmaking trends to look for in 2011
The relationship between the biotechnology and pharmaceutical industries has never been clearer – partner to survive. The Business Forum at the 2011 BIO International Convention is the world’s largest venue for partnering and it might be the best way for emerging companies to find partners . While there are many quality sources for historical deal-trends, the Campbell Alliance and BIO have created the Dealmakers’ Intentions Survey and the BIO One-on-One Partnering Forecast, two unique forward-looking, Read More >
